Literature DB >> 2724428

Endoureteropyelotomy: percutaneous treatment of ureteropelvic junction obstruction.

P J Van Cangh1, J L Jorion, F X Wese, R J Opsomer.   

Abstract

A total of 47 percutaneous operations (endoureteropyelotomy) was performed for treatment of 41 congenital and 6 secondary cases of ureteropelvic junction obstruction between September 1983 and April 1988. Evaluation was available in 39 cases with a followup of 4 to 56 months (mean 16 months). Good results were obtained in 28 of 39 cases (72 per cent) and there were 3 failures (8 per cent). Eight patients (20 per cent) were symptomatically improved but they had residual obstruction on a diuretic study. Only 1 multioperated patient with a good early postoperative result has shown radiological deterioration at 1 year. Complications were managed conservatively, except for 1 case of intravascular coagulopathy. Endoureteropyelotomy is an effective alternative treatment for ureteropelvic junction obstruction but further evaluation definitely is warranted to define better its indications and risk factors.

Entities:  

Mesh:

Year:  1989        PMID: 2724428     DOI: 10.1016/s0022-5347(17)41293-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Endopyelotomy - a Minimally Invasive Surgical Option for Pelvi-ureteric Junction Obstruction: a Study Of 34 Cases.

Authors:  A A Pradhan; Rajeev Sood; P Madhusoodanan; A S Sandhu; S K Gupta; Anil Kumar
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Endopyelotomy for ureteropelvic junction stenosis.

Authors:  W Szewczyk; A Szkodny; A Noga; A Prajsner; G Szkodny
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

3.  Percutaneous endopyelotomy for ureteropelvic junction obstruction.

Authors:  Akiou Okumura; Hideki Fuse; Shinji Tsuritani; Tetsuo Nozaki
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.